Published • loading... • Updated
GOA Therapeutics Appoints Former Gilead Executive Dean Hakanson Chief Medical Officer
Summary by Citybiz
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
GOA Therapeutics Appoints Former Gilead Executive Dean Hakanson Chief Medical Officer
GOA Therapeutics has appointed Dean Hakanson, MD, chief medical officer, bringing a former Gilead Sciences executive to the biotechnology company as it advances an investigational treatment for acute alcohol intoxication toward human clinical trials. Hakanson, a board-certified anesthesiologist with 40 years of experience spanning clinical medicine and biopharmaceutical development, will oversee medical affairs strategy for GOA26, the company’s …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
